|Articles|February 11, 2021
- Pharmaceutical Executive-02-01-2021
- Volume 41
- Issue 2
Pharmaceutical Executive, February 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Pharm Exec at 40over 5 years ago
A Vision of a Fairer Worldover 5 years ago
Coupon-Program Pivot: Meeting New Legal, Operational Hurdlesover 5 years ago
Digital-Communication Check: Insights Learned During Lockdownover 5 years ago
The Best and the Worst on Display in Vaccine Effortover 5 years ago
The Fight for Orphan Drug Research Reform in Europeover 5 years ago
A ‘Golden Year’ for UK Life Sciences Sector?over 5 years ago
A Generational Opportunity for Talent Pipeline Developmentover 5 years ago
Emotional Intelligence Can Help Lead Pharma Through Tough TimesAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
2
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5